Table 4.

Changes and comparisons of pretreatment and posttreatment values within the control group.

		Pretreatment		Posttreatment		Difference		Wilcoxon
		Mean	SD	Mean	SD	Mean	SD	P
1	SNA (°)	81.63	2.5	81.58	2.85	−0.04	1.8
2	SNB (°)	76.13	3.04	76.71	3	0.58	1.24
3	ANB (°)	5.5	1.91	4.88	2.67	−0.63	1.11
4	SN/PP (°)	9.67	3.18	9.17	2.38	−0.5	1.21
5	SN/MP (°)	31	3.48	30.04	3.65	−0.96	1.71	*
6	SE (mm)	20.44	2.61	20.29	2.73	−0.15	0.95
7	SL (mm)	45.48	6.69	46.8	6.99	1.32	2.41
8	Pg-NB (mm)	3.16	2.06	3.12	2.08	−0.04	0.3
9	Ar-Pg (mm)	97.46	5.98	98.27	5.63	0.81	1.06	*
10	A-RL2 (mm)	64.74	3.71	65.15	4.25	0.4	1.45
11	B-RL2 (mm)	55.96	5.2	56.91	5.37	0.96	1.91
12	A-RL1 (mm)	46.98	3.02	46.43	2.77	−0.55	1.18
13	ANS-Me/N-Me (%)	53.93	2.21	54.32	1.63	0.42	1.13
14	Jarabak Ratio (%)	65.84	3.37	66.62	3.37	0.79	0.99	*
15	Gonial Ratio (%)	72.08	4.42	72.54	5.11	0.46	2.16
16	U1/SN (°)	100.21	8.38	101.21	7.93	1	3.26
17	IMPA (°)	98.96	6.63	99.46	6.33	0.5	2.29
18	L1/RL2 (°)	32.67	7.56	32.33	7.43	−0.33	2.49
19	Interincisal Angle (°)	130.42	9.63	129.67	9.2	−0.75	2.84
20	SN/OP (°)	16.29	6.08	15.13	5.22	−1.17	2.72
21	L1/NB (mm)	4.15	1.84	4.08	1.88	−0.07	0.72
22	Overjet (mm)	2.87	1.59	2.94	1.47	0.07	0.81
23	Overbite (mm)	4.82	1.35	4.89	1.43	0.07	0.45
24	U6-RL1 (mm)	62.72	2.48	62.76	2.62	0.04	0.97
25	U1-RL1 (mm)	68.23	2.36	68.56	2.95	0.33	1.35
26	H Angle (°)	10.75	4.05	10.17	3.91	−0.58	2.75
27	Nasolabial Angle (°)	126	11.92	125.58	12.46	−0.42	3.7
28	N-A-Pg (°)	172.29	6.5	173.33	7.16	1.04	2.01
29	A-labialis superior (mm)	20.18	1.95	20.81	2.06	0.62	1.2
30	E line-labialis superior (mm)	−4.26	1.14	−4.41	1.19	−0.15	0.95
31	E line-labialis inferior (mm)	−3.23	1.29	−3.34	1.5	−0.11	0.54
32	Labialis superior-RL2 (mm)	79.15	5.32	80.18	5.78	1.03	1.73
33	Labialis inferior-RL2 (mm)	75	5.11	76.29	4.98	1.29	1.62	*
34	Lip strength (mm)	−2.02	2.8	−1.84	2.98	0.18	1.6

^*:P<.05.